- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BIONEXUS GENE LAB Aktie jetzt für 0€ handeln | |||||
| Mo | Ruanyun Edai Technology Inc.: RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab | 1 | GlobeNewswire (USA) | ||
| 14.08. | BioNexus Gene Lab Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 28.07. | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 28.07. | BioNexus Gene Lab Corp.: BioNexus Advances VitaGuard Southeast Asia Rollout Following China Working Visit | 1 | GlobeNewswire (USA) | ||
| 03.07. | Eastwood Bio-Medical Canada Inc: Eastwood signs research agreement with BioNexus | 1 | Stockwatch | ||
| 05.06. | BioNexus Gene Lab Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 29.05. | BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Cooperation to Move Beyond Trade into Co-Development | 1 | GlobeNewswire (USA) | ||
| 15.05. | BioNexus Gene Lab Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.04. | BioNexus Gene Lab Corp - 10-K, Annual Report | - | SEC Filings | ||
| 11.03. | BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard MRD Platform | 908 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, March 11, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) today announced that, in connection with its Fidelion Diagnostics Pte. Ltd ("Fidelion") transaction... ► Artikel lesen | |
| 23.02. | BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman | 311 | GlobeNewswire (Europe) | Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp.... ► Artikel lesen | |
| 02.12.25 | BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization | 258 | GlobeNewswire (Europe) | SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BGLC" or the "Company"), an emerging provider of precision oncology diagnostics with expanding operations across Southeast... ► Artikel lesen | |
| 20.10.25 | BioNexus Gene Lab Corp.: BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc. | 635 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (Nasdaq: BGLC, "BGLC", or the "Company"), today announced that it has entered into a non-binding Strategic Partnership... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DRAEGERWERK | 115,80 | +1,05 % | Drägerwerk-Aktie // Dicker Freudensprung | Bei Drägerwerk läuft das Geschäft weiterhin sehr gut. Dies belegen überzeugende Zahlen für das erste Halbjahr. So erhöhte sich der Umsatz um 6,2 Prozent auf rund 1,6 Milliarden Euro. Bereinigt wäre... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,03 | +0,05 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| LIFESTANCE HEALTH GROUP | 12,220 | 0,00 % | KeyBanc raises Lifestance Health stock price target on specialty care growth | ||
| HEARTFLOW | 52,24 | +0,06 % | AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion | ||
| ALIGNMENT HEALTHCARE | 8,500 | 0,00 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| AVEANNA HEALTHCARE | 12,400 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| HEARTBEAM | 0,667 | +1,96 % | HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System | ||
| QTREX QUANTUM | 1,565 | +1,62 % | Qtrex Quantum jumps 40% | ||
| ANTERIS TECHNOLOGIES GLOBAL | 7,550 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | ||
| PROGYNY | 25,880 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| GENEDX | 76,15 | -0,16 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BILLIONTOONE | 108,95 | -0,10 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PACS GROUP | 42,740 | 0,00 % | Omega Healthcare transitions 32 Florida facilities to PACS Group | ||
| PRIVIA HEALTH GROUP | 20,480 | +0,15 % | Full Transcript: Privia Health Gr Q2 2026 Earnings Call | ||
| ADAPTHEALTH | 5,750 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
Das Unternehmen BIONEXUS GENE LAB CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,285 Euro und damit -0,39 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIONEXUS GENE LAB CORP finden Sie auf Wallstreet Online.